Immediate Impact
9 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Cystic fibrosis
2024 Standout
Works of Julianna Bailey being referenced
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic
2021
Effect of CFTR Modulators on Anthropometric Parameters in Individuals with Cystic Fibrosis: An Evidence Analysis Center Systematic Review
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Julianna Bailey | 227 | 46 | 101 | 15 | 280 | |
| Amanda Leonard | 179 | 19 | 102 | 15 | 244 | |
| Elizabeth A. Ross | 219 | 25 | 34 | 11 | 320 | |
| Christopher Siracusa | 176 | 38 | 29 | 21 | 233 | |
| Daniel Beever | 49 | 48 | 27 | 18 | 289 | |
| Carlos Bousoño García | 107 | 7 | 53 | 18 | 232 | |
| Emídio Cavalcanti de Albuquerque | 40 | 55 | 31 | 18 | 296 | |
| Marina Litvin | 198 | 10 | 54 | 12 | 329 | |
| Laura González-Saiz | 267 | 10 | 44 | 10 | 302 | |
| Jacqueline Chang | 229 | 29 | 30 | 8 | 290 | |
| K. Pollard | 206 | 22 | 27 | 13 | 272 |
All Works
Login with ORCID to disown or claim papers
Loading papers...